focus -WSS

focus

author：comprehensive 2025-08-12 08:27:47 - browse：419

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： CVS is willing to dump 10% of its Medicare Advantage members

leisure time

WSS

Free medical tuition alone isn't enough to close gaps in primary care

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Lilly’s weekly insulin works as well as daily products, new studies show

STAT reporters are Pulitzer Prize finalists for investigative reporting

WuXi Biologics beefs up its lobbying operation

iTeos Therapeutics debuts first data on TIGIT

explore

focus

explore

Walensky prepares to leave CDC — and Congress — behind

Akili, maker of video game for ADHD, to be acquired for 34 million

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Anesthesiologist group: stop taking Ozempic before surgery

Do more moles mean more problems? Not so, says new study

Medical records are filled with copy

Latest bird flu infection made farmworker sicker than earlier cases

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

focus

Do more moles mean more problems? Not so, says new study

David Sabatini, ex

First Opinion Podcast: What happens when kids become caregivers?

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

STAT series 'Denied by AI' wins major journalism prizes

CVS is willing to dump 10% of its Medicare Advantage members

hotspot

leisure time

entertainment

leisure time